Skip to main content

Day: September 21, 2021

Rackspace Technology Empowers Productivity with Rackspace Elastic Engineering for Microsoft 365

New Offering Delivers Modernized Email and Productivity Applications through a Flexible, Scalable Services Approach SAN ANTONIO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Rackspace Technology® (NASDAQ: RXT), a leading end-to-end multicloud technology solutions company, today announced the launch of Rackspace Elastic Engineering for Microsoft 365. The offering takes a holistic approach to email and productivity application solutions for small, medium, or enterprise customers covering the areas of roadmap and strategy, tech guidance and advice, business process design, enhancements, adoption and ROI, and security and compliance.   Rackspace Elastic Engineering for Microsoft 365 provides accessible, flexible, scalable, and cost-effective services for Microsoft 365, helping maximize value and deliver better business outcomes while modernizing...

Continue reading

Everything Blockchain, Inc. Expands Board with Appointment of Two Independent Directors in Preparation for Up Listing to Senior Exchange

Fleming Island, Florida, Sept. 21, 2021 (GLOBE NEWSWIRE) — Everything Blockchain, Inc., (OTCMKTS:  OBTX) an advanced platform architect, development and services company and software foundry, specializing in blockchain technologies and decentralized processing, announced today that it has expanded its Board of Directors to five directors in anticipation of fulfilling its requirements for an up listing to NASDAQ or the New York Stock Exchange (NYSE).    The Company filled the new positions through unanimous approval of the Board of Directors and a majority of its shareholders.  Richard C. Schaeffer, Jr. and Thomas G Amon accepted the positions on the Board of Directors.  Mr. Schaeffer is a former Senior Executive with the National Security Agency (NSA), with almost 50 years in the Information Security, Cyber Security, and Intelligence...

Continue reading

Oryzon Announces $1 Million Grant From Kabuki Syndrome Philanthropists to Support a Precision Medicine Phase I/II Trial With Vafidemstat

HOPE will be the first clinical trial in precision medicine with vafidemstat in neurodevelopmental diseasesMulticentric study to assess the efficacy of vafidemstat in Kabuki syndrome patientsExpected to start in early 2022In collaboration with the Kennedy-Krieger InstituteMADRID, Spain and CAMBRIDGE, Mass., Sept. 21, 2021 (GLOBE NEWSWIRE) — Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company leveraging epigenetics to develop therapies in diseases with strong unmet medical need, announced today that it has received a one million USD grant to support a new clinical trial with our Phase II LSD1 inhibitor vafidemstat in patients with Kabuki syndrome (KS). The grant was awarded by a patient family whose other philanthropic endeavors include founding the Roya Kabuki clinic at Boston...

Continue reading

Vector Solutions Enters Senior Care Industry with Acquisition of CareSafely

Acquisition Supports Vector’s Mission to Serve Everyday Heroes, Including Three Million Frontline Workers Caring for SeniorsTAMPA, FL & AUSTIN, TX, Sept. 21, 2021 (GLOBE NEWSWIRE) — Vector Solutions, the leading provider of industry-focused software solutions for training, workforce management, and risk communications, has acquired CareSafely, a software and content platform purpose-built to enable senior living and long-term care providers to strengthen their Quality, Safety, and Compliance (QSC) programs. The addition of CareSafely to Vector Solutions supports Vector’s mission to serve everyday heroes by delivering intelligent software solutions that empower them to make safer, smarter, and better decisions, and also introduces a new fast-growing vertical for Vector as the senior care industry employs more...

Continue reading

Islandsbanki hf.: Íslandsbanki issues SEK 750 million Additional Tier 1 notes

Íslandsbanki hf. has today launched its inaugural issue of Additional Tier 1 notes as part of its plan to optimise its capital structure. The issue of SEK 750 million perpetual notes with a 5-year call was placed with investors across Scandinavia and continental Europe and was considerably oversubscribed. The transaction pays a coupon of 3-month STIBOR +475 basis points for the life of the notes and features a temporary write-down structure, a 5.125% CET 1 trigger. The Notes are expected to be rated BB- by Standard & Poors. The issue will be listed on GEM Euronext Dublin on 28 September 2021. Sole Structuring Advisor is UBS Investment Bank. Joint Lead Managers are Danske Bank A/S, Skandinaviska Enskilda Banken AB (Publ) and UBS Investment Bank. Birna Einarsdóttir, CEO of Íslandbanki: “I am greatly encouraged by the warm reception...

Continue reading

Automotive Finco Corp. Announces October 2021 Cash Dividend

Not for distribution to United States newswire services or for dissemination in the United States. This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the securities in the United States. TORONTO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Automotive Finco Corp. (NEX: AFCC-H) (the “Company”) is pleased to announce a cash dividend of $0.0171/common share ($0.205/common share on an annual basis) to be paid on October 29, 2021 to the shareholders of record as of September 29, 2021. The dividend is an eligible dividend. The declaration, amount and payment of future cash dividends are subject to the board of directors’ continuing determination that the payment of dividends are in the best interests of the Company, its shareholders and are in compliance with all laws and agreements of the Company...

Continue reading

BioSig Technologies, Inc. Appoints Medical Device Industry Leader to its Board of Directors

James J. Barry, Ph.D. will join as an Independent Director as Company expands clinical footprint with its signal processing technology for arrhythmia care Westport, CT, Sept. 21, 2021 (GLOBE NEWSWIRE) — BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ECG and intra-cardiac signals, today announced the appointment of James J. Barry, Ph.D. as an Independent Director to its Board of Directors.  Dr. Barry has more than 30 years of experience in the medical device industry as an executive and corporate board director.  He is currently the Principal Owner at Convergent Biomedical Group LLC., a company providing advisory services to the life...

Continue reading

PURA To Launch Farmersville Hemp Brand Marketing Campaign In Q4

DALLAS, TX, Sept. 21, 2021 (GLOBE NEWSWIRE) — Puration, Inc. (OTC Pink: PURA) (“PURA”) has launched a hemp industry-wide strategic initiative to collectively market for multiple hemp growers and processors under a single brand name – Farmersville Hemp. PURA has already forged partnerships with Alkame Holdings, Inc. (OTC Pink: ALKM), North American Cannabis Holdings, Inc. (OTC Pink: USMJ) and PAO Group, Inc. (OTC Pink: PAOG).  Early in Q4, PURA intends to launch a marketing campaign to expand its partnership base. The company recently broke ground on its 70-acre property in Farmersville Texas.  A construction pad has been cleared for the building of multiple buildings where PURA will facilitate hands on marketing for a wide variety of products that can be derived from hemp.  The Farmersville Hemp Brand Facility will be...

Continue reading

Dresner Partners Advised Institute for Human Reproduction In Its Merger With Webster Equity Partners

CHICAGO, Sept. 21, 2021 (GLOBE NEWSWIRE) — Dresner Partners, a leading FINRA-registered, middle-market investment bank and Mergers Alliance member firm, is pleased to announce that it advised the Institute for Human Reproduction (IHR) in its merger with Webster Equity Partners. Terms of the transaction were not disclosed. IHR has been on the forefront of cutting-edge fertility and IVF treatments in the Chicagoland area since 2004. Led by Ilan Tur-Kaspa, M.D. and David Cohen, M.D., IHR specializes in helping individuals and families realize their most cherished family dreams. Drs. Tur-Kaspa and Cohen are joined by a team of dedicated medical professionals to provide a comprehensive range of personalized and effective infertility, IVF and PGT treatments designed to accomplish fertility solutions. Patients come from all over the world...

Continue reading

Blink Charging Awarded Supplier Contract With Sourcewell

– Following a competitive solicitation process Blink EV Chargers are now available to more than 50,000 government, education and non-profit organizations that procure using Sourcewell Miami Beach, Florida, Sept. 21, 2021 (GLOBE NEWSWIRE) — Blink Charging Co. (Nasdaq: BLNK, BLNKW) (“Blink” or the “Company”), a leading owner, operator, and provider of electric vehicle (EV) charging equipment and services, today announced that it has been awarded a cooperative purchasing contract, in the Electric Vehicle Supply Equipment category, from Sourcewell, a self-sustaining government organization that offers contract purchasing solutions. Sourcewell’s cooperative purchasing program includes more than 400 competitively solicited contracts to government, education, and nonprofit entities. Utilizing Sourcewell contracts, participating...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.